VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Dr. Wright Discusses the Molecular Biology of Ovarian Cancer

Jason D. Wright, MD
Published: Tuesday, Nov 25, 2014

Jason D. Wright, MD, Division Chief, Gynecologic Oncology, Associate Clinical Professor of Gynecologic Oncology, Sol Goldman Associate Professor of Obstetrics and Gynecology, Columbia University, discusses the molecular biology of ovarian cancer.

Wright says ovarian cancer tends to be a very heterogeneous disease. Because each tumor is so different, researchers are faced with the challenge of classifying each tumor into subgroups.

Once tumors can be categorized, physicians would have a better idea about who would benefit from each different targeted therapy, Wright says.

Jason D. Wright, MD, Division Chief, Gynecologic Oncology, Associate Clinical Professor of Gynecologic Oncology, Sol Goldman Associate Professor of Obstetrics and Gynecology, Columbia University, discusses the molecular biology of ovarian cancer.

Wright says ovarian cancer tends to be a very heterogeneous disease. Because each tumor is so different, researchers are faced with the challenge of classifying each tumor into subgroups.

Once tumors can be categorized, physicians would have a better idea about who would benefit from each different targeted therapy, Wright says.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Best Practice™: Expert Perspectives to Incorporate Evidence on PARP Inhibitors into Practice and Optimize the Medical Management of Ovarian CancerOct 31, 20181.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x